KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,051 | -79.0% | 14,964 | -39.2% | 0.00% | – |
| Q1 2023 | $95,666 | +5.8% | 24,593 | -7.5% | 0.00% | – |
| Q4 2022 | $90,436 | -54.6% | 26,599 | -27.2% | 0.00% | – |
| Q3 2022 | $199,000 | +76.1% | 36,529 | +45.4% | 0.00% | – |
| Q2 2022 | $113,000 | -68.5% | 25,116 | -48.4% | 0.00% | – |
| Q1 2022 | $359,000 | +45.3% | 48,718 | +26.4% | 0.00% | – |
| Q4 2021 | $247,000 | – | 38,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |